JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okazawa, H.
Right arrow Articles by Takahashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okazawa, H.
Right arrow Articles by Takahashi, M.
Journal of Nuclear Medicine Vol. 44 No. 9 1371-1378
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Differences in Vasodilatory Capacity and Changes in Cerebral Blood Flow Induced by Acetazolamide in Patients with Cerebrovascular Disease

Hidehiko Okazawa, MD, PhD1,2, Hiroshi Yamauchi, MD, PhD1,2, Kanji Sugimoto, MS1 and Masaaki Takahashi1

1 PET Unit, Research Institute, Shiga Medical Center, Moriyama, Japan
2 Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan

To investigate changes in cerebral blood flow (CBF) and blood volume induced by acetazolamide (ACZ) in patients with a variable autoregulatory status responding to reduced perfusion pressure, PET measurements of hemodynamic parameters were performed on patients with cerebrovascular disease, and the relationships between the parameters were evaluated. Methods: Sixteen patients with unilateral major cerebral arterial occlusive disease underwent PET studies with 15O-gas and the steady-state method to obtain hemodynamic parameters in the brain. All patients and 8 healthy volunteers underwent H215O PET at baseline and 10 min after ACZ injection to calculate the CBF and arterial-to-capillary blood volume (V0) based on a 2-compartment model. Results: The regional CBF (rCBF) and V0 increased significantly after ACZ administration in volunteers and in the hemisphere contralateral to the ischemic side in patients. However, in a subgroup of patients with disease who showed a significant reduction in the rCBF increase in the ipsilateral hemisphere, the ACZ challenge caused a decrease in the rCBF even though the V0 showed a significant increase. The reduction in the rCBF increase was associated with an asymmetric increase in oxygen extraction fraction (OEF) but not with an absolute OEF increase. Conclusion: The increases in rCBF and V0 induced by ACZ administration, as well as absolute OEF value in the baseline condition, did not necessarily parallel each other in the ipsilateral hemispheres of patients. Thus, the increase in rCBF after ACZ challenge may not represent vasodilatory capacity in patients with cerebrovascular disease, especially in the regions with a reduced rCBF response.

Key Words: acetazolamide • cerebrovascular disease • cerebral blood flow • vasodilatory capacity • cerebral blood volume




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A.S. Vagal, J.L. Leach, M. Fernandez-Ulloa, and M. Zuccarello
The Acetazolamide Challenge: Techniques and Applications in the Evaluation of Chronic Cerebral Ischemia
AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 876 - 884.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Hokari, S. Kuroda, T. Shiga, N. Nakayama, N. Tamaki, and Y. Iwasaki
Combination of a Mean Transit Time Measurement with an Acetazolamide Test Increases Predictive Power to Identify Elevated Oxygen Extraction Fraction in Occlusive Carotid Artery Diseases
J. Nucl. Med., December 1, 2008; 49(12): 1922 - 1927.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. M. Mandell, J. S. Han, J. Poublanc, A. P. Crawley, J. A. Stainsby, J. A. Fisher, and D. J. Mikulis
Mapping Cerebrovascular Reactivity Using Blood Oxygen Level-Dependent MRI in Patients With Arterial Steno-occlusive Disease: Comparison With Arterial Spin Labeling MRI
Stroke, July 1, 2008; 39(7): 2021 - 2028.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Kuroda, T. Shiga, T. Ishikawa, K. Houkin, T. Narita, C. Katoh, N. Tamaki, and Y. Iwasaki
Reduced Blood Flow and Preserved Vasoreactivity Characterize Oxygen Hypometabolism Due to Incomplete Infarction in Occlusive Carotid Artery Diseases
J. Nucl. Med., June 1, 2004; 45(6): 943 - 949.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.